- Does Tralokinumab Treatment in Atopic Dermatitis Effect COVID-19 and Vaccination?
- Ruxolitinib Treatment for Atopic Dermatitis May Improve Work Productivity
- Freshwater Fish Diet Improves Liver Steatosis in NAFLD
- FDA Pulls Authorization for Bebtelovimab Due to Nonsusceptible SARS-CoV-2 Variants
- Nutritional Supplements May Have Role in Hair Loss Treatment
- Subjective Cognitive Decline Associated With Incident Dementia in Black, Latinx Individuals
- Buprenorphine Use in Pregnancy May Reduce Risk for Adverse Neonatal Outcomes
- Airway Inflammation, Emphysema More Common in Marijuana Smokers
- Microneedling and Minoxidil Combination Effective for Female Pattern Hair Loss
- Brepocitinib Promising for Atopic Dermatitis in Adults
- Social Determinants of Health, Race Impact Outcomes in Pediatric Heart Transplants
- Respiratory Muscle Training Post-COVID Helps Respiratory Muscle Function, HRQoL
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
Overall Symptoms After BNT162b2, Other Vaccines Comparable in Children Younger Than 5 Years
Long COVID Prevalent in Patients With Symptomatic COVID-19 Infection After 1 Year
COVID-19 mRNA Vaccines Tied to Higher Risk for Myocarditis, Pericarditis
FDA Authorizes Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted
HepB-CpG Vaccination Achieves Maximum Seroprotection in Patients With HIV
